Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions

Carvedilol (Cav), a nonselective β-blocker with α1 adrenoceptor blocking effect, has been used as a standard therapy for coronary artery disease. This study investigated the effects of Cav on exosome expression and function, ATP-binding cassette transporter A1 (ABCA1) expression, and cholesterol eff...

Full description

Saved in:
Bibliographic Details
Published in:Int J Mol Sci
Main Authors: Chen, Sy-Jou, Tsui, Pi-Fen, Chuang, Yi-Ping, Chiang, Dapi Meng-Lin, Chen, Liv Weichien, Liu, Shu-Ting, Lin, Feng-Yen, Huang, Shih-Ming, Lin, Shih-Hua, Wu, Wan-Lin, Tsai, Min-Chien, Lin, Chin-Sheng
Format: Artigo
Language:Inglês
Published: MDPI 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834197/
https://ncbi.nlm.nih.gov/pubmed/31635197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20205202
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items